Loading clinical trials...
Loading clinical trials...
This study will investigate the safety and efficacy of oral PF-00299804 in patients who have not yet undergone any other drug treatment for recurrent and/ or metastatic head and neck squamous cell can...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT03429036 · Hearing Disorder, Oral Mucosal Disease, and more
NCT00200486 · Head and Neck Neoplasms
NCT05544136 · Head and Neck Cancer, Head and Neck Carcinoma, and more
NCT06998069 · Head and Neck Neoplasms
NCT06912087 · Head and Neck Neoplasms, Carcinoma, Squamous Cell, and more
BC Cancer Agency, Vancouver Centre
Vancouver, British Columbia
Fairmont Medical Building
Vancouver, British Columbia
Hamilton Health Sciences
Hamilton, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions